Seastar Medical Holding Corp. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.34 M

Shareholding (Mar 2025)

FII

0.25%

Held by 9 FIIs

DII

97.75%

Held by 2 DIIs

Promoter

0.00%

How big is Seastar Medical Holding Corp.?

22-Jun-2025

As of Jun 18, Seastar Medical Holding Corp. has a market capitalization of 10.05 million, with net sales of 0.43 million and a net profit of -15.91 million over the last four quarters. The balance sheet shows shareholder's funds of -2.18 million and total assets of 4.66 million.

What does Seastar Medical Holding Corp. do?

22-Jun-2025

Seastar Medical Holding Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $4 million as of March 2025. It has a market cap of $10.05 million and key metrics indicating significant financial challenges.

Is Seastar Medical Holding Corp. technically bullish or bearish?

20-Sep-2025

As of June 27, 2025, Seastar Medical Holding Corp. is in a mildly bearish trend, with daily moving averages indicating this stance, while it has underperformed significantly with a year-to-date return of -53.61% compared to the S&P 500's 12.22%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 23 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.89

Return on Equity

-448.10%

Price to Book

6.99

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-58.45%

6 Months

-68.78%

1 Year

-84.85%

2 Years

-97.36%

3 Years

-92.39%

4 Years

-96.41%

5 Years

0.0%

Seastar Medical Holding Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Seastar Medical Holding Corp. technically bullish or bearish?

As of 27 June 2025, the technical trend for Seastar Medical Holding Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a mildly bearish trend, while weekly and monthly MACD and RSI readings are mildly bullish and bullish, respectively. However, the Bollinger Bands show a bearish monthly trend, and Dow Theory indicates a mildly bearish stance on both weekly and monthly time frames. In terms of performance, the stock has returned -53.61% year-to-date compared to the S&P 500's 12.22%, and it has significantly underperformed over the past year with a return of -81.71% versus the S&P 500's 17.14%....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

20.96%

EBIT Growth (5y)

-307.72%

EBIT to Interest (avg)

-8.99

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-4.93

Sales to Capital Employed (avg)

0.14

Tax Ratio

0.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.25%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

13.15

EV to EBIT

-0.46

EV to EBITDA

-0.46

EV to Capital Employed

-1.88

EV to Sales

8.22

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-1768.20%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (2.01%)

Foreign Institutions

Held by 9 Foreign Institutions (0.25%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 37.50% vs 13.51% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.80",
          "val2": "-4.70",
          "chgp": "61.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.50",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.00",
          "val2": "-3.20",
          "chgp": "37.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,195.30%",
          "val2": "0.00%",
          "chgp": "-519.53%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.34% vs -114.75% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.80",
          "val2": "-14.20",
          "chgp": "-25.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "1.10",
          "chgp": "-81.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.80",
          "val2": "-9.80",
          "chgp": "30.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-24.80",
          "val2": "-26.20",
          "chgp": "5.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-132,163.00%",
          "val2": "0.00%",
          "chgp": "-13,216.30%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.30

0.00

Operating Profit (PBDIT) excl Other Income

-1.80

-4.70

61.70%

Interest

0.30

0.10

200.00%

Exceptional Items

0.00

1.50

-100.00%

Consolidate Net Profit

-2.00

-3.20

37.50%

Operating Profit Margin (Excl OI)

-5,195.30%

0.00%

-519.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 37.50% vs 13.51% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.10

0.00

Operating Profit (PBDIT) excl Other Income

-17.80

-14.20

-25.35%

Interest

0.20

1.10

-81.82%

Exceptional Items

-6.80

-9.80

30.61%

Consolidate Net Profit

-24.80

-26.20

5.34%

Operating Profit Margin (Excl OI)

-132,163.00%

0.00%

-13,216.30%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.34% vs -114.75% in Dec 2023

All Annual Results

Company CV

About Seastar Medical Holding Corp.

Seastar Medical Holding Corp.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Seastar Medical Holding Corp.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Seastar Medical Holding Corp.?

Watch in Real-Time

What does Seastar Medical Holding Corp. do?

Is Seastar Medical Holding Corp. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Seastar Medical Holding Corp. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Seastar Medical Holding Corp.

Company Coordinates